Publications

  • News for the week of July 16, 2019

    • Justin J. Bates Joins OPA as Chief Executive Officer
    • Last chance to participate in OPA’s Member Survey on Immunization
    • Health Canada finalizes regulations for the production and sale of edible cannabis, cannabis extracts and cannabis topicals

    • Asthma Management: The Essentials
    • Billing 101: Ontario Drug Benefit (ODB) and Third-Party Insurance
    • Opioid Addictions and Substitution Therapy Online Modules

    • Ask the Customer Experience and Administration Team
    • Summer Member Discounts!
    • Summer of Space at the Ontario Science Centre
    • Member Benefit: RxFiles
    • Bonus Offers from TELUS

    • How do I benefit from OPA’s Long Term Disability Insurance?


    • DDD Notice No. 19111 posted July 11, 2019 Drug Shortage / Supply Health System Alert: Rifampin

  • News for the week of July 9, 2019

    • Introducing the 2019-20 OPA Board of Directors
    • OPA 2018-19 Annual Report: Shifting Resilience
    • OPA Survey on Immunization
    • Benefits of Immunization - Report from the International Federation on Ageing
    • University of Toronto Leslie Dan Faculty of Pharmacy Appointments
    • Medical Cannabis Users Survey Results: 1 in 4 medical cannabis users say it's now harder to access cannabis since recreational legalization

    • Injections and Immunizations Certificate Program
    • The Master Plan for Diabetes Continuing Education Program
    • Collaborating with Family Physicians: The Rx for Success

    • Ask the Practice Support Network
    • Summer member discounts!

    • Why Choose OPA Disability Insurance?


    • DDD Notice No. 19106 posted July 5, 2019 Health Network System (HNS) and Narcotics Monitoring System (NMS) Outage Notification to Ontario Drug Programs Agencies
    • DDD Notice No. 19105 posted July 5, 2019 Notice from the Executive Officer
    • DDD Notice No. 19104 posted July 5, 2019 Prescription Forgery Alert
    • DDD Notice No. 19103 posted July 5, 2019 Prescription Forgery Alert
    • DDD Notice No. 19102 posted July 5, 2019 Prescription Forgery Alert
    • DDD Notice No. 19101 posted July 5, 2019 Prescription Forgery Alert
    • DDD Notice No. 19100 posted July 5, 2019 Prescription Forgery Alert

    • Drug Shortage / Supply Health System Alert: Rofact (rifampin)
    • Drug Shortage / Supply Health System Alert: Rifampin
    • Drug Shortage / Supply Health System Alert: Leucovorin
    • Drug Shortage / Supply Health System Alert: Leucovorin, Fludarabine, Jevtana (Cabazitaxel)

  • News for the week of July 2, 2019

    • Drug Supply Health System Alert: Fludarabine Phosphate Injection and Leucovorin Calcium Injection
    • Reminder: Call for OPA Committee Members
    • Call for abstracts - 2020 Traumatic Brain Injury Conference

    • Managing Your Pharmacy: The Business Essentials
    • Essential Cannabis Knowledge for Pharmacy Technicians
    • Assessing and Prescribing for Minor Ailments - Full program

    • Ask the Customer Experience and Administration Team
    • Summer deals with Dell member savings!

    • Stay insured when leaving the country with OPA’s Emergency Travel Insurance


    • Certain older Medtronic MiniMed insulin pumps may be vulnerable to cybersecurity risks
    • Health Product InfoWatch - Vaccine safety biannual summary and pms-Methotrexate monograph update

  • eDIRC: Medical Cannabis Users Survey Results

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    July 4, 2019 volume 17 no 14

  • News for the week of June 25, 2019

    • Second report released from the Premier's Council on Improving Healthcare and Ending Hallway Medicine
    • Reminder: UIIP application deadline is June 30, 2019
    • OPA in the news:
    • Further discussions urged on solutions to opioid crisis
    • Perspectives on pharmacare from OPA
    • Updated Claim Submission/Reversal and Special Authorization (Allergen) Forms
    • ICYMI: Pharmacy student resolutions at OPA AGM
    • OPA launches cannabis program for pharmacy technicians

    • Injections and Immunizations Certificate Program
    • Methadone, Buprenorphine and the Community - live session
    • Patient Assessment and Triage

    • Ask the Practice Support Network

    • Surviving a critical illness

    • DDD Notice No. 19098 posted June 25, 2019 Claim Submission/Reversal and Special Authorization (Allergen) forms
    • DDD Notice No. 19097 posted June 21, 2019 Prescription Forgery Alert
    • DDD Notice No.19096 posted June 21, 2019 Prescription Forgery Alert
    • DDD Notice No. 19095 posted June 21, 2019 Prescription Forgery Alert
    • DDD Notice No. 19093 posted June 21, 2019 Notice from the Executive Officer
    • DDD Notice No. 19092 posted June 20, 2019 ODB FORMULARY – EDITION NO. 43, Summary of Changes – June 2019
    • DDD Notice No. 19091 posted June 19, 2019 REMINDER: Proper Claims Submission Process for ODB Recipients Aged 24 Years and Under
    • Drug Supply Health System Alert: Etoposide and OncoTICE®

    • Important safety information on Alertec (modafinil) and the risk of congenital anomalies

  • OPA Bulletin - June 18, 2019

    • New changes to the Universal Influenza Immunization Program (UIIP) for the upcoming 2019/2020 season
    • Updated evacuation notice for Pikangikum First Nation

    • Drugs in Chronic Kidney Disease: Implications for Pharmacists
    • Musculoskeletal and Nervous System Conditions
    • Implementing Smoking Cessation Services in the Pharmacy

    • Check out PxP2019 Conference photos!
    • Correction Notice: Ask PSN Question from May 28, 2019

    • Business Expense Disability Insurance

    • Drug Shortage Notification for certain Products Presented in LifeShield™ and ANSYR™ Syringes
    • Drug Supply Health System Alert: Leucovorin Calcium Injection, 10 mg/mL, DIN 02087316
    • Drug Supply Health System Alert: Potassium Chloride for Injection Concentrate USP (2mEq/mL) in the 20mL format

    • Health Canada warns Canadians of potential cancer risk associated with gentian violet
    • Labelling error may lead to patients receiving Linessa 28 birth control pills instead of Linessa 21

  • Annual Report 2018-19

    A look at the activities of the Ontario Pharmacists Association over the past Board year (June 2018 – June 2019).

  • OPA Bulletin - June 11, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • ICYMI: PxP2019 update on scope expansion
    • Pharmacy practice research winners at PxP2019
    • Opioid overdose: age is no safety net
    • Updated antiemetic recommendations
    • A limited quantity of U.S.-labeled potassium chloride for injection USP concentrate (2mEq/mL) in the 20mL format will be made available for Canadian patients
    • Fludarabine supply status and conservation strategies

    • Medical Devices Training For Pharmacy Technicians
    • Billing 101: Ontario Drug Benefit (ODB) and Third-Party Insurance
    • Board Certified Geriatric Pharmacist (BCGP) Preparation Course – Medication Therapy Management for Older Adults

    • Ask the Practice Support Network

    • Do I really need life insurance?

    • DDD Notice No. 19086 posted June 05, 2019 Prescription Forgery Alert
    • DDD Notice No. 19087 posted June 06, 2019 Prescription Forgery Alert
    • DDD Notice No. 19090 posted June 10, 2019 Health Network System (HNS) and Narcotic Monitoring System (NMS) outages notification to ODP agencies

    • Health products manufactured by Konsar Future Nutrition Inc. may pose serious health risks

  • OPA Bulletin - June 4, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OPA announces award winners at PxP2019
    • Here's what you're missing at PxP2019!
    • Pikangikum evacuation plan

    • Women’s Health Conditions
    • Managing Your Pharmacy: The Business Essentials
    • Pharmacist Health Coaching - Cardiovascular Program Training Course

    • Ask the Customer Experience and Administration Team

    • Your questions answered on disability insurance

    • DDD Notice No. 19082 posted May 31, 2019 Prescription Forgery Alert
    • DDD Notice No. 19083 posted May 31, 2019 Identified Forgery Alert – 120 Oxycocet Pills
    • DDD Notice No. 19084 posted May 31, 2019 ODB gFOBT PIN to be Discontinued
    • DDD Notice No. 19085 posted June 04, 2019 Notice from the Executive Officer: Change to the Health Network System Subscription Agreement for Pharmacy Operators

    • Health Product InfoWatch - Safety Updates: Eliquis, Fentora and Keytruda
    • Alaris Infusion Sets and Alaris 8100 Pump Module - Health Product Risk Communication - Update – Thursday, May 30th, 2019
    • IMPORTANT: Drug Shortage Notification – Multiple Sterile Injectable Products
    • Biocell breast implants - Information Update

Back to top